Research Paper Volume 15, Issue 16 pp 8408—8432
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
Figure 11. Sensitivity drugs for SART3 high and low expression groups in HCC. Sensitivity drugs for SART3 high expression (A) and SART3 low expression (B). Abbreviations: TKi: Tyrosine kinase inhibitor; HAIC: hepatic arterial infusion chemotherapy; VEGFRi: vascular endothelial growth factor receptor inhibitor; c-METi: c-MET inhibitor; MEK1/2i: mitogen-activated protein kinase 1 and 2 inhibitor; Chemo: Chemotherapy; AurKi: pan-aurora kinase inhibitor; CDKi: Cyclin-dependent kinase inhibitor; mTORC1i: mTOR Complex 1 inhibitor; Pi: proteasome inhibitor.